Product Information
METHYLPHENIDATE ER 18 MG TAB is a generic product labeled by Actavis Pharma, Inc., priced at $0.6192 per EA under NDC 62037072501. Its NADAC has been published 374 times since May 1, 2019.
Strength
18 mg/1
Manufacturer
Actavis Pharma, Inc.NDC
62037072501
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
METHYLPHENIDATE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA076772On Market Since
3/4/2019
Pharmacological Classes
Price Statistics
The NADAC for METHYLPHENIDATE ER 18 MG TAB has been published 374 times since May 1, 2019, and over the history we have for it it has declined 90.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6192 per EA |
|---|---|
| All-time high | $6.1790 (May 15, 2019) |
| All-time low | $0.5230 (Jul 20, 2022) |
| 52-week high | $0.7413 |
| 52-week low | $0.5911 |
| Median price | $0.7337 |
| Average price | $1.4477 |
| Largest weekly change | -50.2% (Jul 22, 2020) |
| Weeks tracked | 374 |
| Tracking since | May 1, 2019 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of METHYLPHENIDATE ER 18 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for METHYLPHENIDATE ER 18 MG TAB, manufactured by Actavis Pharma, Inc., is $0.6192 per EA (NDC 62037072501), effective Jun 24, 2026.
How has the price of METHYLPHENIDATE ER 18 MG TAB changed over time?
Over the history we have for it, the NADAC for METHYLPHENIDATE ER 18 MG TAB has declined 90.0%. It has been tracked across 374 weekly CMS publications since May 1, 2019.
What are the highest and lowest recorded NADAC prices for METHYLPHENIDATE ER 18 MG TAB?
Since May 1, 2019, the NADAC for METHYLPHENIDATE ER 18 MG TAB has ranged from a low of $0.5230 (Jul 20, 2022) to a high of $6.1790 (May 15, 2019), with a median of $0.7337 per EA.
Are there cheaper alternatives to METHYLPHENIDATE ER 18 MG TAB?
5 NADAC-published products share the same active ingredient, strength, and dosage form as METHYLPHENIDATE ER 18 MG TAB, but none are currently priced below it.
Who manufactures METHYLPHENIDATE ER 18 MG TAB?
METHYLPHENIDATE ER 18 MG TAB (NDC 62037072501) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification